Dextromethorphan + Quinidine

GORFETAN®

Dextromethorphan bromhdrate 20 mg / Quinidine sulfate 10 mg. Capsules.


Therapeutical classification:

Dextrometorphan combinations.


How supplied:

GORFETAN® (Dextrometorphan Bromhidrate 20 mg / Quinidin Sulphate

10 mg). Packages containing 60 capsules.


Indications:

Treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrelated neurologic conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the underlying emotional state.


Dose and administration:

The recommended starting dose of GORFETAN® is one capsule daily by mouth for the initial seven days of therapy. On the eighth day of therapy and thereafter, the daily dose should be a total of two capsules a day, given as one capsule every 12 hours. The need for continued treatment should be reassessed periodically, as spontaneous improvement of PBA occurs in some patients.


Storage:

Store at temperatures less than 25°C.

Encarnación Ezcurra 365 Piso 3, C1107CLA, Buenos Aires, Argentina - Phone/Fax: 54 11 5787 2222